US-based radiation oncology systems provider Accuray announced that the CyberKnife Center Salzburg is the first in Austria to treat patients using the CyberKnife System.
The move represents a significant advancement in the availability of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
The use of Accuray’s CyberComm technology significantly reduced commissioning time, allowing the centre to commence patient treatments more swiftly.
Accuray chief medical officer Seth Blacksburg said: “Growing evidence demonstrates that for some indications, ultra-hypofractionation is a proven treatment modality that delivers clinical outcomes as good as conventional fractionation while dramatically reducing the number of treatments and lowering the total cost of care
“This data is driving increased adoption of hypofractionated – and ultra-hypofractionated treatments as the standard of care.
“With this shift we’re seeing more clinicians choose the CyberKnife System, which gives them the confidence they need to deliver efficient, yet effective, treatments to their patients.”
The CyberKnife S7 System is a versatile and precise radiation delivery system that supports the treatment of an expanded range of indications.
It enables ultra-hypofractionated radiation therapy, delivering high doses of precisely targeted radiation in just one to five outpatient sessions.
Unlike conventional methods that often require 30 to 40 sessions, the system offers a more efficient treatment option for patients unable to commit to extended care.
CyberKnife represents a significant advancement in cancer care and offering precise and effective treatment spanning a few days, avoiding weeks of daily sessions.
Accuray president and CEO Suzanne Winter said: “Radiation therapy represents an essential treatment option at each stage of the cancer journey, that’s why we’re committed to providing our customers with the resources they need to get the best possible outcomes with our products.
“We look forward to working with the CyberKnife Center Salzburg team as they pave the way for improving cancer care.
Dr Alfred Haidenberger from CyberKnife Center Salzburg said: “After many years of treating patients as a radiation oncologist in Germany, it was my mission to bring the CyberKnife System to my home country of Austria.
“From my perspective if the patient has an appropriate indication for high-dose radiotherapy, the system is the device of choice.”
